Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke Prevention

INTRODUCTION: Efficacy and safety of vitamin K antagonists (VKAs) among atrial fibrillation (AF) patients are enhanced when the International Normalised Ratio (INR) is 2.0–3.0. Anticoagulation control among older patients is perceived to be lower and contributes to poorer initiation and uptake. OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales: Zulkifly, Hanis, Lip, Gregory Y. H., Lane, Deirdre A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159113/
https://www.ncbi.nlm.nih.gov/pubmed/35685589
http://dx.doi.org/10.1155/2022/5951262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159113/
https://www.ncbi.nlm.nih.gov/pubmed/35685589
http://dx.doi.org/10.1155/2022/5951262

Ejemplares similares